Portuguese pharmaceutical company Bial announced on Tuesday that the Phase 2b (activate) clinical trial evaluating drug BIA 28-6156 in patients with Parkinson’s disease, which was the most [...]
Researchers at Coimbra, Algarve and Évora universities have joined forces with companies for a project that will shortly present the first prototype of a super healthy bread with antioxidant and [...]
Portuguese startup BEAT Therapeutics, a biotechnology company specialising in the development of innovative therapies for highly aggressive cancers such a pancreatic cancer, was the winner of [...]
Portugal is one of the European countries where universities have a greater share in the development and registration of patents, representing one-third of the approximately 800 patents [...]
Over the years innovation has been a key component to the growth and competitiveness of companies in all sectors and the wider economy, and Portugal’s pharmaceutical sector is no exception. New [...]